Endometriosis patients undergoing in vitro fertilization‐embryo transfer (IVF‐ET) treatment suffer from poor oocyte quality, a reduced likelihood of the fertilization rate, and low embryo quality. The dysregulation of immune cells… Click to show full abstract
Endometriosis patients undergoing in vitro fertilization‐embryo transfer (IVF‐ET) treatment suffer from poor oocyte quality, a reduced likelihood of the fertilization rate, and low embryo quality. The dysregulation of immune cells and cytokine profiles in the follicular fluid (FF) may play an important role in the competence of the oocyte and the development of the embryo, but the mechanism remains largely unknown.
               
Click one of the above tabs to view related content.